Search for: "Teva Pharmaceutical"
Results 1 - 20
of 1,422
Sort by Relevance
|
Sort by Date
27 May 2024, 9:26 pm
Teva Pharmaceuticals USA, Inc. [read post]
6 May 2024, 8:26 am
” Warning letters were sent to 10 manufacturers, including, among others, Teva (identifying 58 listings), Novo Nordisk (36 listings), and Boehringer Ingelheim (10 listings). [read post]
1 May 2024, 1:18 pm
Teva Pharmaceuticals, an AKS-based FCA case involving speaker programs sponsored by drug manufacturers, the U.S. [read post]
28 Apr 2024, 8:18 pm
Teva Pharmaceuticals USA, Inc. [read post]
24 Apr 2024, 9:27 pm
Teva Pharmaceuticals USA, Inc. [read post]
16 Apr 2024, 8:42 am
Teva Pharms. [read post]
14 Apr 2024, 9:19 pm
Noonan -- In its recent decision in Janssen Pharmaceuticals, Inc. v. [read post]
8 Apr 2024, 9:47 am
Teva Pharms. [read post]
6 Apr 2024, 8:49 pm
This year's conference co-chairs include Andrei Iancu (Partner, Sullivan & Cromwell LLP and former Director of the USPTO), Brian Malkin (Associate General Counsel, Teva Pharmaceuticals), and Mira Mulvaney (Assistant General Patent Counsel, IP Litigation, Eli Lilly & Company). [read post]
3 Apr 2024, 1:07 pm
The Federal Trade Commission (“FTC”) has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. [read post]
1 Apr 2024, 10:58 am
Teva Pharms. [read post]
1 Apr 2024, 10:15 am
’s patent for a schizophrenia drug are not indefinite but vacated and remanded the district court’s finding that Teva Pharmaceuticals had not proven all of the claims obvious. [read post]
1 Apr 2024, 10:15 am
’s patent for a schizophrenia drug are not indefinite but vacated and remanded the district court’s finding that Teva Pharmaceuticals had not proven all of the claims obvious. [read post]
27 Mar 2024, 10:56 am
” The majority cites the 2015 Federal Circuit decision in Momenta Pharmaceuticals v. [read post]
26 Mar 2024, 7:01 pm
Late last week, the FTC submitted an Amicus Brief in recent Hatch-Waxman patent litigation in the District Court of New Jersey between Reference Listed Drug holder Teva Branded Pharmaceutical Products R&D Inc. and ANDA applicant Amneal Pharmaceuticals explaining that patents that claim the device constituent of a combination product but do not expressly claim the relevant drug substance should not be listed in the Orange Book. [read post]
25 Mar 2024, 4:36 am
Teva Pharmaceuticals. [read post]
7 Mar 2024, 7:42 pm
The first of these is simlandi (adalimumab-ryvk), approved on February 24th, made by Alvotech and Teva Pharmaceuticals, and interchangeable with Humira). [read post]
Celanese v. ITC: Can a Secret Manufacturing Process Be Patented After Sale of the Resulting Product?
4 Mar 2024, 9:45 am
Teva Pharmaceuticals USA, Inc. held that in the AIA, Congress did not change the meaning of “on sale” from the pre-AIA statute. [read post]
19 Feb 2024, 12:55 pm
Teva and Apotex, filed Abbreviated New Drug Applications (ANDAs) with the FDA seeking to market generic versions of the $100m+ drug. [read post]
24 Jan 2024, 6:09 am
About the Paragard Lawsuits The Paragard, an intrauterine device (IUD) manufactured by Teva Pharmaceuticals, has served as a long-term contraceptive method for women since the late 1980s. [read post]